Buy Epithalon Online: $25.00 Paid, 200 Units Delivered

The sequence in order, with the stages that change what you pay marked. Stages three, four and five change only whether you receive anything.

Most guides to buying online stop at stage two. The last stage is the one this site cares about, because it is where an advertised rate turns into a real one. The same six-stage walk, at a different price point, is on our Semax online purchase page.

Four numbers attach to this vial and they need separating, because only one of them is what anybody pays.

The last row is the one people get wrong. Quantity tiers take 3, 5 and 10 percent off the list price for three, five and ten vials, so the best of them lands at $45.00 a vial. The code takes 50 percent off a single vial, so buying one is $25.00. Bulk is the worse rate by a wide margin, and whether the code combines with a tier is documented nowhere on the listing, so treat them as alternatives rather than assuming they stack.

Free carriage begins at $250. At list that is five vials; at the discounted $25.00 it would be ten, if the threshold reads the discounted subtotal, which the listing does not say. That ambiguity is worth resolving in the cart before adding vials to chase free shipping, since ten vials of a research material to reach a carriage threshold is a large commitment against an unstated rule. Our Selank online purchase page works through the same threshold arithmetic on a neighbouring listing.

Payment rails differ in exactly one respect that matters here: what you can do if the box never arrives or arrives wrong. That is worth more than any processing-fee difference.

• Card. The strongest position, because a chargeback is a process you can start unilaterally with a third party who has no stake in the seller. Vendors in this market sometimes route cards through intermediaries, which does not change the underlying protection but can change how the charge is described on a statement.
• Bank transfer. Cheapest for the vendor and weakest for you. Once sent, the money is gone unless the recipient chooses to return it, so this rail asks you to trust the seller completely.
• Digital wallets. Recourse follows whatever funding source sits behind the wallet, so a card-funded wallet inherits card protection and a bank-funded one does not.
• Cryptocurrency. Irreversible by design. A discount offered for paying this way is the seller buying finality from you, and it is worth pricing that against a nine-cent-per-milligram difference before accepting it.

The general rule is simple to apply. Match the strength of the rail to how much you know about the seller, and on a first order with an unfamiliar vendor there is no good reason to give up reversibility to save a small percentage.

The listing states same-day dispatch before 2pm CST and domestic stock. A dispatch cut-off is a description of warehouse behaviour rather than a delivery promise, and the page names no carrier and gives no transit estimate, so the arrival window is genuinely unstated.

What makes that tolerable is the format. The vial ships as a lyophilised powder, frozen and dried under vacuum, containing no water. A dry cake is far more robust in transit than a prepared solution, which is why domestic peptide shipments generally travel as ordinary parcels rather than on a cold chain. Handling requirements change materially once the powder is reconstituted, and that is a bench question rather than a shipping one.

Domestic dispatch also removes the two costs that dominate overseas orders: duty applied on arrival rather than at purchase, and the possibility of a detained parcel becoming a total loss. Neither of those appears in a cart total, which is why a lower headline price on an overseas listing is not a lower landed cost. Our NAD+ online purchase page covers the same stage for a compound where the shipped format is genuinely more fragile.

The first minute after the box is opened is worth spending on paper rather than on the vial. Three things should agree before anything else happens.

The lot code on the vial should read 15-05260628 and match the certificate, which is a Kovera Labs report numbered KVR-2026-A36FF4, certified 23 May 2026, carrying an access code and a verification address at koveralabs.com so the document can be confirmed at the laboratory rather than only on the seller's site. The closure should agree too: the certificate records a red cap and a silver crimp, which is an unusually specific detail and turns the document into something checkable against a physical object.

If the lot code differs from the documented one, the right move is to ask the vendor for that lot's certificate rather than to assume the published one carries over. This matters more here than for the neighbouring compounds, because only one certificate exists for Epithalon at this vendor, where its Selank and Semax listings each carry two from two laboratories. A single documented batch means there is no second lot showing whether testing scope stays consistent between production runs.

The last stage, where an advertised rate becomes a real one. Laboratory handling arithmetic on a research material, and not guidance for administering anything to a person.

A U-100 syringe is graduated so that 100 units equal 1 mL. Add 2 mL of diluent and the label basis gives 5.00 mg/mL, so the vial holds 200 units of graduated volume and 10 units carries 500 mcg. The certificate says the vial holds 9.64 mg, so the same 2 mL actually gives 4.82 mg/mL, and 10 units carries 482 mcg.

The third row is why the ninth cent is worth paying. Because the vendor weighed the vial and printed the result, the volume can be corrected to 1.93 mL and the graduations mean what the label implied. A buyer holding only a label has nothing to correct towards.

Two closing limits, both larger than any of the six stages. A certificate describes a sampled aliquot on a date, before filling, capping and transit, so it is evidence about a production run rather than a promise about a vial. And FDA has written that compounded drugs containing epitalon may pose a risk for immunogenicity because of the potential for aggregation and peptide-related impurities, and that it lacks sufficient information to know whether the drug would cause harm if administered to humans. A clean document answers the first half of that sentence and nothing at all of the second.